1
Sancuso® for Gastroparesis: An Open Label Study.
Condition(s):GastroparesisLast Updated:May 12, 2015Unknown status
Sancuso: 59 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
PK, Tolerability and Safety of the co-Administration of Sancuso® (Transdermal Granisetron) and IV Granisetron
Condition(s):HealthyLast Updated:May 4, 2009Completed
3
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC)
Condition(s):Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)Last Updated:July 25, 2013Completed
4
Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)
Condition(s):HealthyLast Updated:September 27, 2010Completed
5
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy)
Condition(s):Chemotherapy-induced Acute or Delayed Nausea and Vomiting (CINV)Last Updated:August 17, 2012Unknown status
6
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years
Condition(s):Chemotherapy Induced Nausea and VomitingLast Updated:July 13, 2017Completed
7
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years
Condition(s):Chemotherapy Induced Nausea and VomitingLast Updated:January 21, 2020Not yet recruiting
8
Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years
Condition(s):Chemotherapy Induced Nausea and VomitingLast Updated:January 10, 2020Not yet recruiting
9
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC
Condition(s):Chemotherapy-induced Nausea and VomitingLast Updated:December 28, 2016Completed
10
A Phase I Study of the Effects of APF530 Exposure, Granisetron and Moxifloxacin
Condition(s):HealthyLast Updated:August 4, 2015Completed